The presence of laminin in authentic basement membranes was examined at the level of a large pepsin-resistant fragment P1. This strongly antigenic fragment has been recently isolated from a mouse tumour basement membrane. By using antibodies to mouse laminin P1 for identification it was possible to isolate a homologous fragment P1 (Mr about 250000) and a related component Pa (M, about 70000-90000) from pepsin digests of human placenta and kidney. The fragments were rich in half-cystine (90-130 residues/1000) and carbohydrate and showed strong binding to concanavalin A. Reduction of disulphide bonds produced several smaller peptide chains, indicating a complex pepsin cleavage. Immunological assays demonstrated partial antigenic identity between laminin fragments obtained from mouse and human tissue, and suggested that fragment Pa may originate from a protein not completely identical with laminin. The results showed that laminin is an abundant component of tissues rich in basement membranes, which has been previously suggested by immunohistological studies.
Basement membranes are ubiquitous extracellular structures that consist mainly of collagenous and non-collagenous glycoproteins (Kefalides, 1973; Vracko, 1974) . They serve as major filtration barriers between different compartments of the body, such as between blood and urinary tract in the kidney and maternal and foetal circulation in placenta. Owing to the limited knowledge of the structural components in these matrices, their architecture and functional properties are still poorly characterized. Laminin has been identified as a major non-collagenous protein in a mouse tumour basement membrane . It differed from other constituents such as type IV collagen and fibronectin in various chemical and immunological properties. Immunohistological studies indicated that laminin is an abundant structural component Foidart et al., 1980; Alitalo et al., 1980a,b; Madri et al., 1980) , and was found, for example, in all of the renal and placental basement membranes. Laminin production could be demonstrated in the morula (16-32-cell) stage of development (Leivo et al., 1980) and preceded tubule formation in embryonic kidney (Ekblom et al., 1980) , suggesting a crucial role for laminin in the formation of basement membranes.
The characterization of laminin in the tumour (EHS-sarcoma) basement membrane was facilitated by the fact that about 80% of the protein could be extracted in an intact native state by neutral buffer . This approach will not be applicable to most of the authentic basement membranes, since their constituents are largely insoluble, owing to a variety of covalent and non-covalent interactions (Kefalides, 1973) . We had previously shown that most of the disulphide bonds and antigenic determinants of laminin are found in a large fragment P1 resisting proteolytic digestion (Rohde et al., , 1980 . In the present paper we describe the application of pepsin digestion to characterize laminin in human tissues. 
Materials and methods

Materials
Purification oflamininfragments
Pepsin digests were prepared at 6-80C or 150C from human placenta or kidney as described previously (Risteli et al., 1980b) . Large proteins were precipitated from these digests with 1.2 M-NaCl at pH2.5. Precipitated material was dissolved in 50mM-Tris/HCl buffer, pH 7.4, containing 0.2M-NaCl, dialysed overnight against the same buffer (6-80C) and reprecipitated by raising the concentration of NaCl to 2 M and then to 4M. At both concentrations precipitates were obtained containing both collagen and laminin fragments. They were separated from each other on a DEAE-cellulose column (2.5 cm x 25 cm) equilibrated in 50mM-Tris/ HCI buffer, pH8.6, containing 2M-urea, and eluted with a linear (1600ml/1600ml) NaCl gradient (0-0.3 M). The fractions containing laminin fragments were dialysed against 0.2M-ammonium bicarbonate buffer, pH7.9, digested with collagenase (enzyme/substrate ratio 1: 200; 37°C; 1 h) and after being freeze-dried chromatographed on a column (3.0 cm x 85 cm) of Sepharose CL-4B equilibrated in 5mM-Tris/HCl buffer, pH8.6, containing 8M-urea. Samples were then dialysed against water, pH8-9, and freeze-dried. If required, the fragments were further purified on a Sephacryl S-200 column (1.5cm x 110cm) equilibrated in 0.2M-ammonium bicarbonate buffer, pH 8.5, or by binding to a concanavalin A-Sepharose 4B (Pharmacia, Uppsala, Sweden) column (1 cm x 5cm) equilibrated in 50mM-Tris/HCl buffer, pH 7.4, containing 0.15 M-NaCl and 1 mM-CaCl2 (protein load 5-10mg). Material bound to the lectin was displaced by elution with 0.4 M-a-methyl mannoside, and the column was regenerated by elution with 50% (v/v) ethylene glycol in the same buffer (Anttinen et al., 1977) . All chromatographic operations were performed at room temperature. The presence of fragments of human laminin in the various fractions was monitored by gel diffusion with antiserum to mouse laminin P1. Fragment P1 from soluble and insoluble mouse laminin was prepared as described previously (Rohde et al., 1980) .
Chemical methods
The amino acid composition was determined on a Durrum D-500 analyser after hydrolysis of the samples with 6M-HCI (110°C; 16h) under N2.
Hexoses were determined by the orcinol reaction (Frangois et al., 1962) , with galactose as standard.
Individual sugars were identified, after hydrolysis (4M-HCI; 110°C; 3h), by t.l.c. (Miller & Sinn, 1977) . Polyacrylamide-gel electrophoresis was performed in the presence of 2% (w/v) sodium dodecyl sulphate (Furthmayr & Timpl, 1971 ) before or after reduction with 5% (v/v) 2-mercaptoethanol. The runs were calibrated for molecular-weight determination with reduced mouse laminin (M, 220000, 440000), fibronectin (M, 450000), immunoglobulin G (Mr 140000), serum albumin (Mr 68 000), ovalbumin (Mr 45 000) and cytochrome c (Mr 13 000).
Immunological assays
Rabbit antisera against fragments P1 and Pa of human and mouse laminin were prepared by following a previously described schedule . They were analysed by radioimmunoassay and by gel diffusion in 1% agarose by using established procedures .
Results
Isolation oflaminin peptides P1 and Pafrom human placenta and kidney Pepsin digestion of human tissues solubilized fragments that showed, in gel diffusion, partial cross-reaction with antibodies to fragment P1 of mouse tumour laminin (Fig. la) . By using these antibodies as an analytical tool, it was possible to purify two related fragments P1 and Pa from these digests. Both fragments were separated from collagen on DEAE-cellulose ( Effluent volume (ml) Fig. 2 . Purification of fragments P1 and Pa of human placenta obtained from a pepsin digest of placenta by chromatography on DEAE-cellulose (a) and on Sepharose CL-4B (b) The DEAE-cellulose column (2.5 cm x 25 cm) was equilibrated in 50mM-Tris/HCI buffer, pH 8.6, containing 2 M-urea and was eluted with a linear gradient of 0-0.3 M-NaCl. The Sepharose column (3.0 cm x 85 cm) was equilibrated in 5 mM-Tris/HCI buffer, pH 8.6, containing 8 M-urea. The arrows denote the start of the gradient (G) and the void volume (V0) and total volume (THO) of the column. For further details see the text. Most of the collagenous protein did not bind to DEAE-cellulose (Risteli et al., 1980b) and could be removed from laminin fragments. 
The column (I cm x 5 cm) was ec chromatography (Fig. 2b ) after brief digestion with collagenase in order to destroy residual collagen. Both fragments showed strong affinity for concanavalin A, which was useful for final purification (Fig. 3) . The final yields from human placenta were about 10-15mg of fragment P1 and 5mg of fragment Pa per kg wet wt. of tissue. Similar fragments could be prepared from human kidney in about 5-fold lower yields. Chemical properties Fragments P1 and Pa from human placenta both (3) had similar amino acid compositions, which were characterized by a high cysteine content (Table 1) . They closely resembled those of laminin P1 from the mouse tumour (Rohde et al., 1980 (Fig. 4) (4) human placenta fragment Pa. The same samples were examined after reduction with 5% mercaptoethanol in a gel of higher porosity: (5) mouse fragment P1, (6) human placenta-fragment P 1 and (7) human placenta fragment Pa. The arrows denote the migration positions of appropriate molecular-weight markers (10-3 x Mr). For further details see the text. slightly smaller molecular weight of about 250000 was estimated for the human fragment P1 on the basis of electrophoretic mobility. As expected, fragment Pa was distinctly smaller and showed a main band with Mr 70000-90000. Reduction of these fragments with mercaptoethanol produced a complex band pattern that was related to but not identical with that found with fragment P1 of mouse laminin (Fig. 4) . This indicated differences in pepsin-susceptibility of mouse and human laminins.
Immunochemical characterization
Antisera against fragment P1 of mouse laminin showed a line of partial antigenic identity with corresponding fragments from human placenta and kidney in gel diffusion (Fig. la) . This finding was corroborated by radioimmunoassays showing for the human fragments partial inhibitory activity not exceeding 30-40% of the total reaction (Fig. Sa) . If the same antiserum, however, was reacted against labelled human peptide P1 (Fig. 5b) then both mouse and human antigens showed complete inhibition, with slight differences in affinity. The data indicate that the various fragments resemble homologous portions of the same protein, and the incomplete cross-reaction is presumably due to interspecies variations in certain structural features.
Fragments P1 and Pa from human placenta were also good immunogens in rabbits, and produced strong precipitin reactions (Fig. lb) heterogeneous appearance of mouse fragment P1, it was found to be homogeneous in the ultracentrifuge, with M, 290000 (Rohde et al., 1980) . A radioimmunoassay (Fig. 6) . No large differences were noted between fragments P1 and Pa from human placenta and kidney when they were examined in both assays with antisera to fragment P1 (Figs. lb and 7a ). Antisera to fragment Pa could distinguish between fragments Pa and P1 (Fig. 7b) , indicating that the former peptide possessed additional antigenic determinants not shared with fragment P 1.
The antisera against human laminin showed no cross-reaction with human fibronectin (Fig. 7) but a distinct although weak cross-reaction with mouse laminin fragment P1 (Figs. 1, 6 and 7) . Antigenicity was largely destroyed by reduction and alkylation of disulphide bonds in the presence of 8 M-urea (Fig. 7) .
It was also possible to detect in human serum antigenic material related to the fragments of laminin by radioimmunoinhibition assay (results not shown). The concentrations found in serum were in the range 1OS50ng/ml. These low concentrations explain why no positive reaction was observed in the less-sensitive gel-diffusion assay (Fig. 1) .
Discussion
Laminin has so far been isolated only as an intact molecule from a solid mouse tumour and as chain constituents from a mouse teratocarcinoma cell line (Chung et al., 1979) .
Cell-culture studies have demonstrated that human tissues should possess a protein with similar subunits (Alitalo et al., 1980a,b) . Preliminary studies on neutral-salt extracts prepared from human placenta showed only negligible amounts of laminin when judged by radioimmunoassay (L. Risteli & R. Timpl, unpublished work) . This may be due to the small amount of basement membrane and/or to the low Concn. of inhibitor (ng/ml) Fig. 7 . Inhibition of the reaction of antiserum tofragment P1 and labelledfragment Pl (a) and ofantiserum to fragment Pa and labelledfragment Pa (b), bothfrom human placenta Inhibitors of these reactions were fragments P1 from human placenta, (a), human kidney (0) and mouse tumour (A), fragments Pa from human placenta (l) and kidney (0), and reduced and alkylated fragments P1 from human placenta (V) and human plasma fibronectin (A). For further details see the text. solubility of laminin in placenta. A substantial portion of the protein could, however, be solubilized by pepsin digestion in the form of fragments P1 and Pa, which are highly resistant to proteinases. Similar procedures have been previously used to solubilize other basement-membrane components from placenta, such as type-IV collagen fragments (Glanville et al., 1979; Bailey et al., 1979; Sage et al., 1979; Kresina & Miller, 1979) and 7S collagen (Risteli et al., 1980b (Rohde et al., 1980) . The results were interpreted as indicating that these smaller fragments are derived from laminin-like proteins and not from laminin.
The procedure described in the present paper should be useful for isolating laminin fragments from a variety of other tissues. It was possible, for example, to prepare small amounts of a similar fragment from bovine lens capsule, which is another basement membrane (L. Risteli & R. Timpl, unpublished work) . If antibodies are not available to identify the fragments, other characteristic properties, such as electrophoretic mobility before and after reduction, the high cystine content and strong affinity for concanavalin A, may be useful for monitoring purification. Binding of concanavalin A to the glomerular basement membrane in situ has been demonstrated (Shibata et al., 1977) and may be due to interaction with laminin.
Fragments of mouse and human laminins showed partial immunological cross-reactions in the range 15-40%. Similar interspecies differences have been noted with antibodies against intact laminin when used in tissue absorption studies . Antibodies raised against mouse fragment P1 showed complete cross-reaction with intact laminin, indicating that the release of the fragment is not accompanied by substantial structural changes (Rohde et al., , 1980 . Thus antibodies against similar human fragments described here should be useful, as in previous studies, to analyse the tissue distribution of laminin in normal Foidart et al., 1980; Madri et al., 1980) and pathological Hahn et al., 1980) states and during embryonic development (Leivo et al., 1980; Ekblom et al., 1980) . Small amounts of laminin antigen could also be detected in the circulation, and this is presumably derived from the endothelium lining the vascular wall. With the aid of radioimmunoassays it should be possible to detect pathological changes by monitoring the serum concentration of laminin (Risteli et al., 1980a) .
